Another explanation might be that as many different miRs are upregulated in CLL cells, they can also be responsible for abnormal BTLA expression and in consequence could partially mask the effect of miR-155-5p inhibition. Here, BTLA is linked to B-cell chronic lymphocytic leukemia.